Dogs of all sizes, shapes, ages and breeds united today to “Doggupy” New York City’s Union Square Park, turning out for a demonstration to demand nutritious, real, whole food and call for an end to the inferior kibble that they’ve been fed for too long. Camped out in an army of pup tents, they woof-woofed as one, urging canines across America to join the Merrick Pet Care real food revolution — a commitment to only manufacture food that’s locally sourced, high in protein and made in the USA — and help provide “food worthy of a fork” to their fellow dogs in need.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58180-merrick-pet-care-doggupy-nyc-union-square-park-real-dog-food-revolution
The thinking that diet does not affect acne is a falsehood perpetuated by that part of the medical industry that is trying to protect their livelihood of dispensing drugs. The AMA has established that the only way to deal with acne is through the use of medication. They say there is no evidence to support the idea that diet causes acne.
Results from the global Diabetes Attitudes, Wishes and Needs 2 study (DAWN2™) presented today at a symposium during the World Diabetes Congress of the International Diabetes Federation (IDF), show that only 29% of people with diabetes report that their healthcare team ask for their input when making their treatment plans. Furthermore, only 33% said they were encouraged by their healthcare professional to ask questions in the consultation.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64152-novo-nordisk-diabetes-report-doctor-treatment
The millions of women who experience bladder leakage now have a new option to strengthen and tone away their problem instead of covering it up with pads.
The PeriCoach System is a discreet device and smartphone app that helps women perform at-home pelvic floor muscle training, exercises recommended by the American College of Physicians as first-line treatment for urinary incontinence. PeriCoach is the only system that includes a web portal allowing clinicians to remotely monitor their patients’ progress.
To view the Multimedia News Release, go http://www.multivu.com/players/English/7543451-pericoach-fda-approval/
Casio America, Inc. re-entered the professional synthesizer market this year with the launch of two products ideal for performing and recording artists – the XW-P1 Performance Synthesizer and the XW-G1 Groove Synthesizer. Based on the successful introduction of the XW series, Casio has teamed up with aNYthing, a streetwear/lifestyle brand located in New York City, to create a limited edition XW-P1 synthesizer. Designed in a signature gold hue, only 200 XW-P1GD units will be available at Guitar Center and Musician’s Friend.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57776-casio-anything-xw-p1-performance-synthesizer-and-xw-g1-groove-synthesizer
What do you think of this music video? Love can really drive some people to do crazy things! The main character in this story only wants the best for her man, even if it means going into an area that is off limits; his sacred garage.
http://www.facebook.com/DIYNetwork
The Asthma and Allergy Foundation of America (AAFA) and Teva Respiratory released results today from a new survey which showed that more than half (59 percent) of nasal allergy sufferers polled reported sleep issues as a result of their allergy symptoms, yet only 35 percent proactively treat their nasal allergy symptoms. Furthermore, nearly half of those surveyed (48 percent) said their nasal allergy symptoms, such as nasal congestion and sneezing, also interrupted their partner’s sleep.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60975-teva-respiratory-aafa-ditch-the-drip-misty-may-treanor-nasal-allergies
A recent study found that only 47% of Americans are currently taking steps to prevent bone loss1, despite considering it to be of high importance. In an effort to educate the public about the importance of bone health, Sunsweet Growers has partnered with the International Osteoporosis Foundation (IOF) to support their annual World Osteoporosis Day (WOD) campaign. WOD is globally celebrated on October 20 and serves to create awareness for bone health and the steps that can be taken to protect bones including incorporating bone-building habits – like eating prunes – into a regular lifestyle routine.
Bones need the right nutrients to stay strong and healthy and research suggests that eating just 5-6 prunes (the Feel Good Fruit!) each day may help to prevent bone loss. However, many do not think about bone health until after a fracture or break occurs.
To view the multimedia release go to:
https://www.multivu.com/players/English/8410051-sunsweet-iof-world-osteoporosis-day-bone-health/
As facts go, we’re used to extraordinary numbers in the tech world, yet certain realities continue to astonish: each day on the planet, more iPhones are sold than babies are born. Access to information is constantly at our fingertips, keeping us connected virtually at all times; but moments when we are face-to-face merit attention as well. Kendall-Jackson, a family-owned winery that handcrafts high-quality wines, is changing the way wine can be part of those everyday occasions with family and friends. Introducing “Goes Well With Friends,” your official permission to enjoy wine however, whenever and with whomever you choose. Instead of only pairing wine with food, Kendall-Jackson invites you to pair wine selections with your experiences and mood, such as a night out with friends, a quiet dinner for two or a family gathering.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58948-kendall-jackson-discover-k-j-recommends-wine-app
Tried and tested that Lithium ion batt is the only thing that can give life to a lonely, lifeless and poor CP. This clip proves it. This is the best clip! Two thumbs up! Vote Now!
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
